Preliminary Data from a Phase 1/2 Study of a Gene Therapy for X-Linked Retinitis Pigmentosa has been Shared
Free-Photos / Pixabay

Preliminary Data from a Phase 1/2 Study of a Gene Therapy for X-Linked Retinitis Pigmentosa has been Shared

Nightstar Therapeutics has released preliminary data from a Phase 1/2 study of an experimental gene therapy designed to treat X-linked retinitis pigmentosa. For more detailed information you can view the…

Continue Reading Preliminary Data from a Phase 1/2 Study of a Gene Therapy for X-Linked Retinitis Pigmentosa has been Shared

Researchers are Looking into How RNA Affects Parkinson’s Disease and Psychiatric Disorders

A study carried out by researchers from Harvard Medical School and Brigham and Women’s Hospital has explored the link between dopamine neurones, Parkinson’s disease, and psychiatric disorders. To read about…

Continue Reading Researchers are Looking into How RNA Affects Parkinson’s Disease and Psychiatric Disorders
A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria
Alexas_Fotos / Pixabay

A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria

According to a story from Medical Xpress, an international group of scientists from the US, France, and Spain may have discovered that an antifungal agent commonly used to treat skin…

Continue Reading A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria
The FDA Has Awarded Orphan Drug Designation to a Therapy for Complications After Haematopoietic Cell Transplantation
qimono / Pixabay

The FDA Has Awarded Orphan Drug Designation to a Therapy for Complications After Haematopoietic Cell Transplantation

The United States Food and Drug Administration has awarded Orphan Drug Designation to an experimental PLX cell therapy (called PLX-R18) as a treatment for graft failure and incomplete haematopoietic recovery…

Continue Reading The FDA Has Awarded Orphan Drug Designation to a Therapy for Complications After Haematopoietic Cell Transplantation
Experimental Treatment for Anemia Associated With Beta Thalassemia Gets Fast Track Designation
allinonemovie / Pixabay

Experimental Treatment for Anemia Associated With Beta Thalassemia Gets Fast Track Designation

According to a story from PR Newswire, the drug developer Protagonist Therapeutics recently announced that its investigational therapy PTG-300 has earned Fast Track designation from the US Food and Drug…

Continue Reading Experimental Treatment for Anemia Associated With Beta Thalassemia Gets Fast Track Designation
The FDA has Awarded Over $18 Million for Rare Disease Research
kropekk_pl / Pixabay

The FDA has Awarded Over $18 Million for Rare Disease Research

The United States Food and Drug Administration has awarded twelve research grants worth a total of over $18 million for research into rare diseases. For more information about this news,…

Continue Reading The FDA has Awarded Over $18 Million for Rare Disease Research
Clinical Trial Data Looking Promising for an Experimental Amyotrophic Lateral Sclerosis Treatment
DarkoStojanovic / Pixabay

Clinical Trial Data Looking Promising for an Experimental Amyotrophic Lateral Sclerosis Treatment

According to a story from BioSpace, the biotechnology company BioElectron recently announced that the results from its Phase 2a clinical trial of its experimental product EPI-589 are looking positive. EPI-589…

Continue Reading Clinical Trial Data Looking Promising for an Experimental Amyotrophic Lateral Sclerosis Treatment

Cambridge Researchers Find That Gene Editing Could Help Treat Mitochondrial Diseases

According to a story from UPI, gene editing technology could be a potential treatment for mitochondrial diseases, a rare, genetic illness that is usually fatal. In a proof-of-concept experiment, researchers…

Continue Reading Cambridge Researchers Find That Gene Editing Could Help Treat Mitochondrial Diseases
Experimental Treatment Shuts Down Hereditary Angioedema Attacks Quickly in Trials
Free-Photos / Pixabay

Experimental Treatment Shuts Down Hereditary Angioedema Attacks Quickly in Trials

According to a story from Angioedema News, an investigational product from BioCryst Pharmaceuticals called BCX7353 was able to quickly subdue swelling attacks in hereditary angioedema in clinical trials. In addition,…

Continue Reading Experimental Treatment Shuts Down Hereditary Angioedema Attacks Quickly in Trials
Preliminary Data from a Phase 1/2 Study of a Gene Therapy for Haemophilia A has been Shared
Bru-nO / Pixabay

Preliminary Data from a Phase 1/2 Study of a Gene Therapy for Haemophilia A has been Shared

Sangamo Therapeutics has shared details of their preliminary data from a clinical trial of the investigational drug SB-525 in patients with Haemophilia A. For more detailed information, you can read…

Continue Reading Preliminary Data from a Phase 1/2 Study of a Gene Therapy for Haemophilia A has been Shared

Clinical Trial for Duchenne Muscular Dystrophy Gene Therapy Restarts After Hold Lifted

According to a story from statnews.com, the drug developer Sarepta has recently announced the its clinical trial testing an experimental gene therapy has resumed after the FDA lifted the hold.…

Continue Reading Clinical Trial for Duchenne Muscular Dystrophy Gene Therapy Restarts After Hold Lifted

A Group of Disorders Share Similarities in Their DNA 3D Folding Patterns, Researchers Say

Researchers at the University of Pennsylvania have studied the genetics of a class of neurological disorders that includes Huntington’s disease and Fragile X Syndrome. They found that there were similarities…

Continue Reading A Group of Disorders Share Similarities in Their DNA 3D Folding Patterns, Researchers Say
Use of Canadian Marijuana Approved For Tremor Research
https://pixabay.com/en/marijuana-leaves-cannabis-green-3678222/

Use of Canadian Marijuana Approved For Tremor Research

According to medicalexpress.com, the United States government recently approved the import of marijuana extracts from Canada. Though an uncommon occurrence, the US government approved the import for a clinical trial…

Continue Reading Use of Canadian Marijuana Approved For Tremor Research
Clinical Trials For Multiple Myeloma and Other Diseases Fail to Reflect Racial Demographics
Pexels / Pixabay

Clinical Trials For Multiple Myeloma and Other Diseases Fail to Reflect Racial Demographics

According to a story from Mother Jones, patients of black or Native American backgrounds are consistently underrepresented in clinical trials. This occurs even when the trials are for diseases that…

Continue Reading Clinical Trials For Multiple Myeloma and Other Diseases Fail to Reflect Racial Demographics

This New Tech Allows Scientists to Observe The Natural Behavior of Pancreatic Cancer Cells

According to a story from EurekAlert! a cell culture platform developed by scientists associated with Hokkaido University will allow researchers to record and observe the natural behaviors of cancer cells.…

Continue Reading This New Tech Allows Scientists to Observe The Natural Behavior of Pancreatic Cancer Cells
Increasing Collaboration and Partnership is Enhancing The Development of Rare Disease Drugs
rawpixel / Pixabay

Increasing Collaboration and Partnership is Enhancing The Development of Rare Disease Drugs

According to a story from Research & Development, increasing collaboration between a variety of different organizations is helping to propel and improve the develop of new drugs for the treatment…

Continue Reading Increasing Collaboration and Partnership is Enhancing The Development of Rare Disease Drugs